Regional Differences in Metronidazole Resistance and Increasing Clarithromycin Resistance among Helicobacter pylori Isolates from Japan-Reference-Cited by-同舟云学术

Regional Differences in Metronidazole Resistance and Increasing Clarithromycin Resistance among Helicobacter pylori Isolates from Japan

Published:2000-08 Issue:8 Volume:44 Page:2214-2216
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Kato Mototsugu¹,Yamaoka Yoshio²³,Kim Jae J.³,Reddy Rita³,Asaka Masahiro⁴,Kashima Kei²,Osato Michael S.³,El-Zaatari Fouad A. K.³,Graham David Y.³,Kwon Dong H.³

Affiliation:

1. Department of Endoscopy1 and

2. Third Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kyoto,3 Japan, and

3. Department of Medicine, Baylor College of Medicine, Veterans Affairs Medical Center, Houston, Texas2

4. Third Department of Internal Medicine,4 Hokkaido University School of Medicine, Sapporo, and

Abstract

ABSTRACT The patterns of antibiotic resistance in Helicobacter pylori were assessed in two different regions in Japan. Overall, prevalences of resistance to metronidazole and clarithromycin were 12.4 and 12.9%, respectively. While there was no difference in clarithromycin resistance, the prevalence of metronidazole resistance was significantly higher in Kyoto (23.8%) than in Sapporo (8.1%). From 1996 to 1999, the prevalence of metronidazole resistance did not change but the prevalence of clarithromycin resistance doubled (from 9.1 to 18.7%).

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.44.8.2214-2216.2000

Reference18 articles.

1. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin—influence on treatment outcome.;Adamek R. J.;Am. J. Gastroenterol.,1998

2. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands.;Debets-Ossenkopp Y. J.;J. Antimicrob. Chemother.,1999

3. Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori.;European Study Group on Antibiotic Susceptibility of Helicobacter pylori;Eur. J. Clin. Microbiol. Infect. Dis.,1992

4. Metronidazole resistance in Helicobacter pylori.;Glupczynski Y.;Lancet,1990

5. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model.;Graham D. Y.;Gastroenterology,1997

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the Antimicrobial Effects of Glycyrrhiza glabra and Salvia officinalis Ethanolic Extract Against Helicobacter pylori;International Journal of Infection;2021-09-10

2. Vonoprazan-Based Triple-Therapy Could Improve Efficacy of the Tailored Therapy of Helicobacter pylori Infection;Journal of Gastrointestinal and Liver Diseases;2019-12-09

3. Antibiotic dispensation rates among participants in community-driven health research projects in Arctic Canada;BMC Public Health;2019-07-15

4. Effect of Age on Effectiveness of Vonoprazan in Triple Therapy for Helicobacter pylori Eradication;Internal Medicine;2019-06-01

5. Nationwide antibiotic resistance mapping of Helicobacter pylori in Korea: A prospective multicenter study;Helicobacter;2019-05-20